Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.92 - $1.56 $34,128 - $57,869
37,096 New
37,096 $40,000
Q3 2022

Nov 14, 2022

BUY
$0.34 - $1.12 $5,994 - $19,745
17,630 New
17,630 $11,000
Q4 2021

Feb 14, 2022

SELL
$1.11 - $2.56 $11,255 - $25,958
-10,140 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.29 - $3.14 $23,220 - $31,839
10,140 New
10,140 $25,000

About NLS Pharmaceutics Ltd.


  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $55.5M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.